Global Oncology Small Molecule Drugs Market Size, Status and Forecast 2024-2031

Report ID: 934892 | Published Date: Oct 2024 | No. of Page: 126 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Oncology Small Molecule Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Chemotherapy Drugs
        1.2.3 Immunomodulating Drugs
        1.2.4 Targeted Therapy Drugs
        1.2.5 Hormonal Therapy
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global Oncology Small Molecule Drugs Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Blood Cancer
        1.3.3 Breast Cancer
        1.3.4 Gastrointestinal Cancer
        1.3.5 Prostate Cancer
        1.3.6 Lung Cancer
        1.3.7 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Oncology Small Molecule Drugs Market Perspective (2016-2027)
    2.2 Oncology Small Molecule Drugs Growth Trends by Regions
        2.2.1 Oncology Small Molecule Drugs Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Oncology Small Molecule Drugs Historic Market Share by Regions (2016-2021)
        2.2.3 Oncology Small Molecule Drugs Forecasted Market Size by Regions (2022-2027)
    2.3 Oncology Small Molecule Drugs Industry Dynamic
        2.3.1 Oncology Small Molecule Drugs Market Trends
        2.3.2 Oncology Small Molecule Drugs Market Drivers
        2.3.3 Oncology Small Molecule Drugs Market Challenges
        2.3.4 Oncology Small Molecule Drugs Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Oncology Small Molecule Drugs Players by Revenue
        3.1.1 Global Top Oncology Small Molecule Drugs Players by Revenue (2016-2021)
        3.1.2 Global Oncology Small Molecule Drugs Revenue Market Share by Players (2016-2021)
    3.2 Global Oncology Small Molecule Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Oncology Small Molecule Drugs Revenue
    3.4 Global Oncology Small Molecule Drugs Market Concentration Ratio
        3.4.1 Global Oncology Small Molecule Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Oncology Small Molecule Drugs Revenue in 2020
    3.5 Oncology Small Molecule Drugs Key Players Head office and Area Served
    3.6 Key Players Oncology Small Molecule Drugs Product Solution and Service
    3.7 Date of Enter into Oncology Small Molecule Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology Small Molecule Drugs Breakdown Data by Type
    4.1 Global Oncology Small Molecule Drugs Historic Market Size by Type (2016-2021)
    4.2 Global Oncology Small Molecule Drugs Forecasted Market Size by Type (2022-2027)

5 Oncology Small Molecule Drugs Breakdown Data by Application
    5.1 Global Oncology Small Molecule Drugs Historic Market Size by Application (2016-2021)
    5.2 Global Oncology Small Molecule Drugs Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Oncology Small Molecule Drugs Market Size (2016-2027)
    6.2 North America Oncology Small Molecule Drugs Market Size by Type
        6.2.1 North America Oncology Small Molecule Drugs Market Size by Type (2016-2021)
        6.2.2 North America Oncology Small Molecule Drugs Market Size by Type (2022-2027)
        6.2.3 North America Oncology Small Molecule Drugs Market Size by Type (2016-2027)
    6.3 North America Oncology Small Molecule Drugs Market Size by Application
        6.3.1 North America Oncology Small Molecule Drugs Market Size by Application (2016-2021)
        6.3.2 North America Oncology Small Molecule Drugs Market Size by Application (2022-2027)
        6.3.3 North America Oncology Small Molecule Drugs Market Size by Application (2016-2027)
    6.4 North America Oncology Small Molecule Drugs Market Size by Country
        6.4.1 North America Oncology Small Molecule Drugs Market Size by Country (2016-2021)
        6.4.2 North America Oncology Small Molecule Drugs Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Oncology Small Molecule Drugs Market Size (2016-2027)
    7.2 Europe Oncology Small Molecule Drugs Market Size by Type
        7.2.1 Europe Oncology Small Molecule Drugs Market Size by Type (2016-2021)
        7.2.2 Europe Oncology Small Molecule Drugs Market Size by Type (2022-2027)
        7.2.3 Europe Oncology Small Molecule Drugs Market Size by Type (2016-2027)
    7.3 Europe Oncology Small Molecule Drugs Market Size by Application
        7.3.1 Europe Oncology Small Molecule Drugs Market Size by Application (2016-2021)
        7.3.2 Europe Oncology Small Molecule Drugs Market Size by Application (2022-2027)
        7.3.3 Europe Oncology Small Molecule Drugs Market Size by Application (2016-2027)
    7.4 Europe Oncology Small Molecule Drugs Market Size by Country
        7.4.1 Europe Oncology Small Molecule Drugs Market Size by Country (2016-2021)
        7.4.2 Europe Oncology Small Molecule Drugs Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Oncology Small Molecule Drugs Market Size (2016-2027)
    8.2 Asia-Pacific Oncology Small Molecule Drugs Market Size by Type
        8.2.1 Asia-Pacific Oncology Small Molecule Drugs Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Oncology Small Molecule Drugs Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Oncology Small Molecule Drugs Market Size by Type (2016-2027)
    8.3 Asia-Pacific Oncology Small Molecule Drugs Market Size by Application
        8.3.1 Asia-Pacific Oncology Small Molecule Drugs Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Oncology Small Molecule Drugs Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Oncology Small Molecule Drugs Market Size by Application (2016-2027)
    8.4 Asia-Pacific Oncology Small Molecule Drugs Market Size by Region
        8.4.1 Asia-Pacific Oncology Small Molecule Drugs Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Oncology Small Molecule Drugs Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Oncology Small Molecule Drugs Market Size (2016-2027)
    9.2 Latin America Oncology Small Molecule Drugs Market Size by Type
        9.2.1 Latin America Oncology Small Molecule Drugs Market Size by Type (2016-2021)
        9.2.2 Latin America Oncology Small Molecule Drugs Market Size by Type (2022-2027)
        9.2.3 Latin America Oncology Small Molecule Drugs Market Size by Type (2016-2027)
    9.3 Latin America Oncology Small Molecule Drugs Market Size by Application
        9.3.1 Latin America Oncology Small Molecule Drugs Market Size by Application (2016-2021)
        9.3.2 Latin America Oncology Small Molecule Drugs Market Size by Application (2022-2027)
        9.3.3 Latin America Oncology Small Molecule Drugs Market Size by Application (2016-2027)
    9.4 Latin America Oncology Small Molecule Drugs Market Size by Country
        9.4.1 Latin America Oncology Small Molecule Drugs Market Size by Country (2016-2021)
        9.4.2 Latin America Oncology Small Molecule Drugs Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Oncology Small Molecule Drugs Market Size (2016-2027)
    10.2 Middle East & Africa Oncology Small Molecule Drugs Market Size by Type
        10.2.1 Middle East & Africa Oncology Small Molecule Drugs Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Oncology Small Molecule Drugs Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Oncology Small Molecule Drugs Market Size by Type (2016-2027)
    10.3 Middle East & Africa Oncology Small Molecule Drugs Market Size by Application
        10.3.1 Middle East & Africa Oncology Small Molecule Drugs Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Oncology Small Molecule Drugs Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Oncology Small Molecule Drugs Market Size by Application (2016-2027)
    10.4 Middle East & Africa Oncology Small Molecule Drugs Market Size by Country
        10.4.1 Middle East & Africa Oncology Small Molecule Drugs Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Oncology Small Molecule Drugs Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Oncology Small Molecule Drugs Introduction
        11.1.4 Roche Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.1.5 Roche Recent Development
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Oncology Small Molecule Drugs Introduction
        11.2.4 Novartis Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.2.5 Novartis Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Details
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Oncology Small Molecule Drugs Introduction
        11.3.4 Pfizer Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.3.5 Pfizer Recent Development
    11.4 Celgene
        11.4.1 Celgene Company Details
        11.4.2 Celgene Business Overview
        11.4.3 Celgene Oncology Small Molecule Drugs Introduction
        11.4.4 Celgene Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.4.5 Celgene Recent Development
    11.5 Bristol-Myers Squibb
        11.5.1 Bristol-Myers Squibb Company Details
        11.5.2 Bristol-Myers Squibb Business Overview
        11.5.3 Bristol-Myers Squibb Oncology Small Molecule Drugs Introduction
        11.5.4 Bristol-Myers Squibb Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.5.5 Bristol-Myers Squibb Recent Development
    11.6 Amgen
        11.6.1 Amgen Company Details
        11.6.2 Amgen Business Overview
        11.6.3 Amgen Oncology Small Molecule Drugs Introduction
        11.6.4 Amgen Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.6.5 Amgen Recent Development
    11.7 Johnson & Johnson
        11.7.1 Johnson & Johnson Company Details
        11.7.2 Johnson & Johnson Business Overview
        11.7.3 Johnson & Johnson Oncology Small Molecule Drugs Introduction
        11.7.4 Johnson & Johnson Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.7.5 Johnson & Johnson Recent Development
    11.8 AbbVie
        11.8.1 AbbVie Company Details
        11.8.2 AbbVie Business Overview
        11.8.3 AbbVie Oncology Small Molecule Drugs Introduction
        11.8.4 AbbVie Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.8.5 AbbVie Recent Development
    11.9 Sanofi
        11.9.1 Sanofi Company Details
        11.9.2 Sanofi Business Overview
        11.9.3 Sanofi Oncology Small Molecule Drugs Introduction
        11.9.4 Sanofi Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.9.5 Sanofi Recent Development
    11.10 Takeda
        11.10.1 Takeda Company Details
        11.10.2 Takeda Business Overview
        11.10.3 Takeda Oncology Small Molecule Drugs Introduction
        11.10.4 Takeda Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.10.5 Takeda Recent Development
    11.11 Eli Lilly
        11.11.1 Eli Lilly Company Details
        11.11.2 Eli Lilly Business Overview
        11.11.3 Eli Lilly Oncology Small Molecule Drugs Introduction
        11.11.4 Eli Lilly Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.11.5 Eli Lilly Recent Development
    11.12 Bayer
        11.12.1 Bayer Company Details
        11.12.2 Bayer Business Overview
        11.12.3 Bayer Oncology Small Molecule Drugs Introduction
        11.12.4 Bayer Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.12.5 Bayer Recent Development
    11.13 AstraZeneca
        11.13.1 AstraZeneca Company Details
        11.13.2 AstraZeneca Business Overview
        11.13.3 AstraZeneca Oncology Small Molecule Drugs Introduction
        11.13.4 AstraZeneca Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.13.5 AstraZeneca Recent Development
    11.14 Astellas
        11.14.1 Astellas Company Details
        11.14.2 Astellas Business Overview
        11.14.3 Astellas Oncology Small Molecule Drugs Introduction
        11.14.4 Astellas Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.14.5 Astellas Recent Development
    11.15 Merck
        11.15.1 Merck Company Details
        11.15.2 Merck Business Overview
        11.15.3 Merck Oncology Small Molecule Drugs Introduction
        11.15.4 Merck Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.15.5 Merck Recent Development
    11.16 Biogen Idec
        11.16.1 Biogen Idec Company Details
        11.16.2 Biogen Idec Business Overview
        11.16.3 Biogen Idec Oncology Small Molecule Drugs Introduction
        11.16.4 Biogen Idec Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.16.5 Biogen Idec Recent Development
    11.17 Eisai
        11.17.1 Eisai Company Details
        11.17.2 Eisai Business Overview
        11.17.3 Eisai Oncology Small Molecule Drugs Introduction
        11.17.4 Eisai Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.17.5 Eisai Recent Development
    11.18 Teva
        11.18.1 Teva Company Details
        11.18.2 Teva Business Overview
        11.18.3 Teva Oncology Small Molecule Drugs Introduction
        11.18.4 Teva Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.18.5 Teva Recent Development
    11.18 Otsuka
        .1 Otsuka Company Details
        .2 Otsuka Business Overview
        .3 Otsuka Oncology Small Molecule Drugs Introduction
        .4 Otsuka Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        .5 Otsuka Recent Development
    11.20 Ipsen
        11.20.1 Ipsen Company Details
        11.20.2 Ipsen Business Overview
        11.20.3 Ipsen Oncology Small Molecule Drugs Introduction
        11.20.4 Ipsen Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.20.5 Ipsen Recent Development
    11.21 Gilead Sciences
        11.21.1 Gilead Sciences Company Details
        11.21.2 Gilead Sciences Business Overview
        11.21.3 Gilead Sciences Oncology Small Molecule Drugs Introduction
        11.21.4 Gilead Sciences Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.21.5 Gilead Sciences Recent Development
    11.22 Exelixis
        11.22.1 Exelixis Company Details
        11.22.2 Exelixis Business Overview
        11.22.3 Exelixis Oncology Small Molecule Drugs Introduction
        11.22.4 Exelixis Revenue in Oncology Small Molecule Drugs Business (2016-2021)
        11.22.5 Exelixis Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Oncology Small Molecule Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Chemotherapy Drugs
    Table 3. Key Players of Immunomodulating Drugs
    Table 4. Key Players of Targeted Therapy Drugs
    Table 5. Key Players of Hormonal Therapy
    Table 6. Key Players of Other
    Table 7. Global Oncology Small Molecule Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Oncology Small Molecule Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Oncology Small Molecule Drugs Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Oncology Small Molecule Drugs Market Share by Regions (2016-2021)
    Table 11. Global Oncology Small Molecule Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Oncology Small Molecule Drugs Market Share by Regions (2022-2027)
    Table 13. Oncology Small Molecule Drugs Market Trends
    Table 14. Oncology Small Molecule Drugs Market Drivers
    Table 15. Oncology Small Molecule Drugs Market Challenges
    Table 16. Oncology Small Molecule Drugs Market Restraints
    Table 17. Global Oncology Small Molecule Drugs Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Oncology Small Molecule Drugs Market Share by Players (2016-2021)
    Table 19. Global Top Oncology Small Molecule Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Small Molecule Drugs as of 2020)
    Table 20. Ranking of Global Top Oncology Small Molecule Drugs Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Oncology Small Molecule Drugs Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Oncology Small Molecule Drugs Product Solution and Service
    Table 24. Date of Enter into Oncology Small Molecule Drugs Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Oncology Small Molecule Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Oncology Small Molecule Drugs Revenue Market Share by Type (2016-2021)
    Table 28. Global Oncology Small Molecule Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Oncology Small Molecule Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Oncology Small Molecule Drugs Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Oncology Small Molecule Drugs Revenue Market Share by Application (2016-2021)
    Table 32. Global Oncology Small Molecule Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Oncology Small Molecule Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Oncology Small Molecule Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Oncology Small Molecule Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Oncology Small Molecule Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Oncology Small Molecule Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Oncology Small Molecule Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Oncology Small Molecule Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Oncology Small Molecule Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Oncology Small Molecule Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Oncology Small Molecule Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Oncology Small Molecule Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Oncology Small Molecule Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Oncology Small Molecule Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Oncology Small Molecule Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Oncology Small Molecule Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Oncology Small Molecule Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Oncology Small Molecule Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Oncology Small Molecule Drugs Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Oncology Small Molecule Drugs Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Oncology Small Molecule Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Oncology Small Molecule Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Oncology Small Molecule Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Oncology Small Molecule Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Oncology Small Molecule Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Oncology Small Molecule Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Oncology Small Molecule Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Oncology Small Molecule Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Oncology Small Molecule Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Oncology Small Molecule Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Oncology Small Molecule Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Oncology Small Molecule Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Roche Company Details
    Table 65. Roche Business Overview
    Table 66. Roche Oncology Small Molecule Drugs Product
    Table 67. Roche Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 68. Roche Recent Development
    Table 69. Novartis Company Details
    Table 70. Novartis Business Overview
    Table 71. Novartis Oncology Small Molecule Drugs Product
    Table 72. Novartis Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 73. Novartis Recent Development
    Table 74. Pfizer Company Details
    Table 75. Pfizer Business Overview
    Table 76. Pfizer Oncology Small Molecule Drugs Product
    Table 77. Pfizer Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 78. Pfizer Recent Development
    Table 79. Celgene Company Details
    Table 80. Celgene Business Overview
    Table 81. Celgene Oncology Small Molecule Drugs Product
    Table 82. Celgene Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 83. Celgene Recent Development
    Table 84. Bristol-Myers Squibb Company Details
    Table 85. Bristol-Myers Squibb Business Overview
    Table 86. Bristol-Myers Squibb Oncology Small Molecule Drugs Product
    Table 87. Bristol-Myers Squibb Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 88. Bristol-Myers Squibb Recent Development
    Table 89. Amgen Company Details
    Table 90. Amgen Business Overview
    Table 91. Amgen Oncology Small Molecule Drugs Product
    Table 92. Amgen Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 93. Amgen Recent Development
    Table 94. Johnson & Johnson Company Details
    Table 95. Johnson & Johnson Business Overview
    Table 96. Johnson & Johnson Oncology Small Molecule Drugs Product
    Table 97. Johnson & Johnson Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 98. Johnson & Johnson Recent Development
    Table 99. AbbVie Company Details
    Table 100. AbbVie Business Overview
    Table 101. AbbVie Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 102. AbbVie Recent Development
    Table 103. Sanofi Company Details
    Table 104. Sanofi Business Overview
    Table 105. Sanofi Oncology Small Molecule Drugs Product
    Table 106. Sanofi Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 107. Sanofi Recent Development
    Table 108. Takeda Company Details
    Table 109. Takeda Business Overview
    Table 110. Takeda Oncology Small Molecule Drugs Product
    Table 111. Takeda Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 112. Takeda Recent Development
    Table 113. Eli Lilly Company Details
    Table 114. Eli Lilly Business Overview
    Table 115. Eli Lilly Oncology Small Molecule Drugs Product
    Table 116. Eli Lilly Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 117. Eli Lilly Recent Development
    Table 118. Bayer Company Details
    Table 119. Bayer Business Overview
    Table 120. Bayer Oncology Small Molecule Drugs Product
    Table 121. Bayer Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 122. Bayer Recent Development
    Table 123. AstraZeneca Company Details
    Table 124. AstraZeneca Business Overview
    Table 125. AstraZeneca Oncology Small Molecule Drugs Product
    Table 126. AstraZeneca Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 127. AstraZeneca Recent Development
    Table 128. Astellas Company Details
    Table 129. Astellas Business Overview
    Table 130. Astellas Oncology Small Molecule Drugs Product
    Table 131. Astellas Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 132. Astellas Recent Development
    Table 133. Merck Company Details
    Table 134. Merck Business Overview
    Table 135. Merck Oncology Small Molecule Drugs Product
    Table 136. Merck Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 137. Merck Recent Development
    Table 138. Biogen Idec Company Details
    Table 139. Biogen Idec Business Overview
    Table 140. Biogen Idec Oncology Small Molecule Drugs Product
    Table 141. Biogen Idec Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 142. Biogen Idec Recent Development
    Table 143. Eisai Company Details
    Table 144. Eisai Business Overview
    Table 145. Eisai Oncology Small Molecule Drugs Product
    Table 146. Eisai Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 147. Eisai Recent Development
    Table 148. Teva Company Details
    Table 149. Teva Business Overview
    Table 150. Teva Oncology Small Molecule Drugs Product
    Table 151. Teva Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 152. Teva Recent Development
    Table 153. Otsuka Company Details
    Table 154. Otsuka Business Overview
    Table 155. Otsuka Oncology Small Molecule Drugs Product
    Table 156. Otsuka Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 157. Otsuka Recent Development
    Table 158. Ipsen Company Details
    Table 159. Ipsen Business Overview
    Table 160. Ipsen Oncology Small Molecule Drugs Product
    Table 161. Ipsen Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 162. Ipsen Recent Development
    Table 163. Gilead Sciences Company Details
    Table 164. Gilead Sciences Business Overview
    Table 165. Gilead Sciences Oncology Small Molecule Drugs Product
    Table 166. Gilead Sciences Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 167. Gilead Sciences Recent Development
    Table 168. Exelixis Company Details
    Table 169. Exelixis Business Overview
    Table 170. Exelixis Oncology Small Molecule Drugs Product
    Table 171. Exelixis Revenue in Oncology Small Molecule Drugs Business (2016-2021) & (US$ Million)
    Table 172. Exelixis Recent Development
    Table 173. Research Programs/Design for This Report
    Table 174. Key Data Information from Secondary Sources
    Table 175. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oncology Small Molecule Drugs Market Share by Type: 2020 VS 2027
    Figure 2. Chemotherapy Drugs Features
    Figure 3. Immunomodulating Drugs Features
    Figure 4. Targeted Therapy Drugs Features
    Figure 5. Hormonal Therapy Features
    Figure 6. Other Features
    Figure 7. Global Oncology Small Molecule Drugs Market Share by Application: 2020 VS 2027
    Figure 8. Blood Cancer Case Studies
    Figure 9. Breast Cancer Case Studies
    Figure 10. Gastrointestinal Cancer Case Studies
    Figure 11. Prostate Cancer Case Studies
    Figure 12. Lung Cancer Case Studies
    Figure 13. Other Case Studies
    Figure 14. Oncology Small Molecule Drugs Report Years Considered
    Figure 15. Global Oncology Small Molecule Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 16. Global Oncology Small Molecule Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 17. Global Oncology Small Molecule Drugs Market Share by Regions: 2020 VS 2027
    Figure 18. Global Oncology Small Molecule Drugs Market Share by Regions (2022-2027)
    Figure 19. Global Oncology Small Molecule Drugs Market Share by Players in 2020
    Figure 20. Global Top Oncology Small Molecule Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Small Molecule Drugs as of 2020
    Figure 21. The Top 10 and 5 Players Market Share by Oncology Small Molecule Drugs Revenue in 2020
    Figure 22. Global Oncology Small Molecule Drugs Revenue Market Share by Type (2016-2021)
    Figure 23. Global Oncology Small Molecule Drugs Revenue Market Share by Type (2022-2027)
    Figure 24. North America Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. North America Oncology Small Molecule Drugs Market Share by Type (2016-2027)
    Figure 26. North America Oncology Small Molecule Drugs Market Share by Application (2016-2027)
    Figure 27. North America Oncology Small Molecule Drugs Market Share by Country (2016-2027)
    Figure 28. United States Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Canada Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Europe Oncology Small Molecule Drugs Market Share by Type (2016-2027)
    Figure 32. Europe Oncology Small Molecule Drugs Market Share by Application (2016-2027)
    Figure 33. Europe Oncology Small Molecule Drugs Market Share by Country (2016-2027)
    Figure 34. Germany Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. France Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. U.K. Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Italy Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Russia Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Nordic Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Asia-Pacific Oncology Small Molecule Drugs Market Share by Type (2016-2027)
    Figure 42. Asia-Pacific Oncology Small Molecule Drugs Market Share by Application (2016-2027)
    Figure 43. Asia-Pacific Oncology Small Molecule Drugs Market Share by Region (2016-2027)
    Figure 44. China Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Japan Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. South Korea Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Southeast Asia Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. India Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Australia Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Latin America Oncology Small Molecule Drugs Market Share by Type (2016-2027)
    Figure 52. Latin America Oncology Small Molecule Drugs Market Share by Application (2016-2027)
    Figure 53. Latin America Oncology Small Molecule Drugs Market Share by Country (2016-2027)
    Figure 54. Mexico Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Brazil Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Middle East & Africa Oncology Small Molecule Drugs Market Share by Type (2016-2027)
    Figure 58. Middle East & Africa Oncology Small Molecule Drugs Market Share by Application (2016-2027)
    Figure 59. Middle East & Africa Oncology Small Molecule Drugs Market Share by Country (2016-2027)
    Figure 60. Turkey Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. Saudi Arabia Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. UAE Oncology Small Molecule Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. Roche Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 64. Novartis Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 65. Pfizer Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 66. Celgene Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 68. Amgen Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 69. Johnson & Johnson Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 70. AbbVie Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 71. Sanofi Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 72. Takeda Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 73. Eli Lilly Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 74. Bayer Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 75. AstraZeneca Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 76. Astellas Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 77. Merck Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 78. Biogen Idec Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 79. Eisai Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 80. Teva Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 81. Otsuka Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 82. Ipsen Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 83. Gilead Sciences Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 84. Exelixis Revenue Growth Rate in Oncology Small Molecule Drugs Business (2016-2021)
    Figure 85. Bottom-up and Top-down Approaches for This Report
    Figure 86. Data Triangulation
    Figure 87. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Novartis
Pfizer
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
AbbVie
Sanofi
Takeda
Eli Lilly
Bayer
AstraZeneca
Astellas
Merck
Biogen Idec
Eisai
Teva
Otsuka
Ipsen
Gilead Sciences
Exelixis
Frequently Asked Questions
Oncology Small Molecule Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oncology Small Molecule Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oncology Small Molecule Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Pension Insurance

Pension insurance is an insurance that specifies pension plan contributions to an insurance under ... Read More

Life Reinsurance

Reinsurance, also known as insurance for insurers or stop-loss insurance, is the practice of insu ... Read More